首页 > 最新文献

IBJ Clinical Pharmacology最新文献

英文 中文
Experiencia en el uso de biomarcadores farmacogenéticos en la práctica clínica: Hospital La Fe (VALENCIA). 在临床实践中使用药物遗传生物标志物的经验:la Fe医院(巴伦西亚)。
Pub Date : 2019-10-02 DOI: 10.24217/2530-4984.19s2v1s1.00006
S. Pellicer
{"title":"Experiencia en el uso de biomarcadores farmacogenéticos en la práctica clínica: Hospital La Fe (VALENCIA).","authors":"S. Pellicer","doi":"10.24217/2530-4984.19s2v1s1.00006","DOIUrl":"https://doi.org/10.24217/2530-4984.19s2v1s1.00006","url":null,"abstract":"","PeriodicalId":257309,"journal":{"name":"IBJ Clinical Pharmacology","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127767001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
El papel de los consorcios en el futuro de la farmacogenética: Proyecto Pharmvar. 联盟在药物遗传学未来的作用:Pharmvar项目。
Pub Date : 2019-10-02 DOI: 10.24217/2530-4984.19s2v1s1.00008
Cáceres. n, J. A. García-Agúndez
{"title":"El papel de los consorcios en el futuro de la farmacogenética: Proyecto Pharmvar.","authors":"Cáceres. n, J. A. García-Agúndez","doi":"10.24217/2530-4984.19s2v1s1.00008","DOIUrl":"https://doi.org/10.24217/2530-4984.19s2v1s1.00008","url":null,"abstract":"","PeriodicalId":257309,"journal":{"name":"IBJ Clinical Pharmacology","volume":"70 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123132922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experiencia en el uso de biomarcadores farmacogenéticos en la práctica clínica: Hospital General de Alicante. 在临床实践中使用药物遗传生物标志物的经验:阿利坎特总医院。
Pub Date : 2019-10-02 DOI: 10.24217/2530-4984.19s2v1s1.00004
Alicante España. Farmacología Clínica. Departamento de Salud Alican, Alicante España. Neurofarmacología del Dolor, A. Peiró
{"title":"Experiencia en el uso de biomarcadores farmacogenéticos en la práctica clínica: Hospital General de Alicante.","authors":"Alicante España. Farmacología Clínica. Departamento de Salud Alican, Alicante España. Neurofarmacología del Dolor, A. Peiró","doi":"10.24217/2530-4984.19s2v1s1.00004","DOIUrl":"https://doi.org/10.24217/2530-4984.19s2v1s1.00004","url":null,"abstract":"","PeriodicalId":257309,"journal":{"name":"IBJ Clinical Pharmacology","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121821866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ensayo clínico aleatorizado para evaluar dos pautas de administración del ibuprofeno en el tratamiento del ductus arterioso persistente eco-guiado. 评估布洛芬在生态引导持续性动脉导管治疗中的两种给药模式的随机临床试验。
Pub Date : 2019-06-12 DOI: 10.24217/2530-4984.19V1S1.00012
M. Bravo
Patent ductus arteriosus (PDA) is a common condition of preterm infants and it is associated with significant morbidity and mortality. The best therapeutic option for PDA closure remains controversial. Necrotizing enterocolitis (NEC) and bowel spontaneous perforation have been observed in those infants who received pharmacologic treatment of PDA. Conventional treatment of PDA consists on 3 daily doses of intravenous (iv) ibuprofen in bolus 10-5-5 mg/kg/day. Recently, it has been shown that intravenous continuous infusion of ibuprofen (10-5-5 mg/kg/day) seems to be more effective for PDA closure than the conventional treatment with iv bolus. Our group demonstrated in a recent pilot study that the Echocardiographically guided treatment, EchoG, of PDA when it is compared with the conventional treatment, is feasible and reduces the number of ibuprofen doses. Thus, EchoG treatment potentially reduces the adverse events associated with ibuprofen (i.e lower rate of NEC in the experimental group). This multicenter study will evaluate whether the combination of both experimental therapies (EchoG and iv continuous infusions) reduces the incidence of bowel adverse events (NEC and bowel spontaneous perforation) as compared with EchoG and iv ibuprofen bolus.
动脉导管未闭(PDA)是早产儿的一种常见疾病,它与显著的发病率和死亡率相关。PDA闭合的最佳治疗选择仍有争议。坏死性小肠结肠炎(NEC)和肠道自发穿孔已在接受药物治疗的婴儿中观察到。PDA的常规治疗包括每日3次静脉注射(iv)布洛芬,每次10-5-5毫克/公斤/天。最近,有研究表明,静脉持续输注布洛芬(10-5-5 mg/kg/天)似乎比传统的静脉注射治疗更有效。我们小组在最近的一项初步研究中证明,与传统治疗相比,PDA的超声心动图引导治疗(EchoG)是可行的,并且减少了布洛芬的剂量。因此,超声心动图治疗可能减少与布洛芬相关的不良事件(即实验组NEC发生率较低)。这项多中心研究将评估与EchoG和静脉注射布洛芬相比,两种实验疗法(EchoG和静脉连续输注)联合使用是否能降低肠道不良事件(NEC和肠道自发穿孔)的发生率。
{"title":"Ensayo clínico aleatorizado para evaluar dos pautas de administración del ibuprofeno en el tratamiento del ductus arterioso persistente eco-guiado.","authors":"M. Bravo","doi":"10.24217/2530-4984.19V1S1.00012","DOIUrl":"https://doi.org/10.24217/2530-4984.19V1S1.00012","url":null,"abstract":"Patent ductus arteriosus (PDA) is a common condition of preterm infants and it is associated with significant morbidity and mortality. The best therapeutic option for PDA closure remains controversial. Necrotizing enterocolitis (NEC) and bowel spontaneous perforation have been observed in those infants who received pharmacologic treatment of PDA. Conventional treatment of PDA consists on 3 daily doses of intravenous (iv) ibuprofen in bolus 10-5-5 mg/kg/day. Recently, it has been shown that intravenous continuous infusion of ibuprofen (10-5-5 mg/kg/day) seems to be more effective for PDA closure than the conventional treatment with iv bolus. Our group demonstrated in a recent pilot study that the Echocardiographically guided treatment, EchoG, of PDA when it is compared with the conventional treatment, is feasible and reduces the number of ibuprofen doses. Thus, EchoG treatment potentially reduces the adverse events associated with ibuprofen (i.e lower rate of NEC in the experimental group). This multicenter study will evaluate whether the combination of both experimental \u0000therapies (EchoG and iv continuous infusions) reduces the incidence of bowel adverse events (NEC and bowel spontaneous perforation) as compared with EchoG and iv ibuprofen bolus.","PeriodicalId":257309,"journal":{"name":"IBJ Clinical Pharmacology","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128875890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Infección por Parvovirus B19 como imitadora de DRESS. 模仿DRESS的细小病毒B19感染。
Pub Date : 2017-11-09 DOI: 10.24217/2530-4984.17v1s1.00007
A. R. Mariblanca, L. D. García, I. García, J. M. Villatoro, E. R. García, M. Moreno, Alberto M. Borobia Pérez
{"title":"Infección por Parvovirus B19 como imitadora de DRESS.","authors":"A. R. Mariblanca, L. D. García, I. García, J. M. Villatoro, E. R. García, M. Moreno, Alberto M. Borobia Pérez","doi":"10.24217/2530-4984.17v1s1.00007","DOIUrl":"https://doi.org/10.24217/2530-4984.17v1s1.00007","url":null,"abstract":"","PeriodicalId":257309,"journal":{"name":"IBJ Clinical Pharmacology","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2017-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117251835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
¿DRESS o Pustulosis? Esa es la cuestión. 衣服还是脓疱病?这就是问题所在。
Pub Date : 2017-11-09 DOI: 10.24217/2530-4984.17v1s1.00006
A. G. Duarte, A. Zubiaur, A. Q. Cortés, M. Bandini, I. H. Surmann, Ilena Medina Expósito, Alberto M. Borobia Pérez
{"title":"¿DRESS o Pustulosis? Esa es la cuestión.","authors":"A. G. Duarte, A. Zubiaur, A. Q. Cortés, M. Bandini, I. H. Surmann, Ilena Medina Expósito, Alberto M. Borobia Pérez","doi":"10.24217/2530-4984.17v1s1.00006","DOIUrl":"https://doi.org/10.24217/2530-4984.17v1s1.00006","url":null,"abstract":"","PeriodicalId":257309,"journal":{"name":"IBJ Clinical Pharmacology","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2017-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132594288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tratamiento oftalmológico agudo del paciente con necrolisis epidérmica tóxica. 中毒性表皮坏死溶解患者的急性眼科治疗。
Pub Date : 2017-11-09 DOI: 10.24217/2530-4984.17v1s1.00002
M. G. Ruiz, Alberto M. Borobia Pérez
{"title":"Tratamiento oftalmológico agudo del paciente con necrolisis epidérmica tóxica.","authors":"M. G. Ruiz, Alberto M. Borobia Pérez","doi":"10.24217/2530-4984.17v1s1.00002","DOIUrl":"https://doi.org/10.24217/2530-4984.17v1s1.00002","url":null,"abstract":"","PeriodicalId":257309,"journal":{"name":"IBJ Clinical Pharmacology","volume":"73 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2017-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116265566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Necrólisis epidérmica tóxica causada por Pilexil champú: serenoa serrulata vs hidantoína. Pilexil洗发水引起的中毒性表皮坏死溶解:serenoa serrulata vs hidantoin。
Pub Date : 2017-11-09 DOI: 10.24217/2530-4984.17V1S1.00004
A. R. Mariblanca, L. D. García, I. García, E. R. García, Kapil Laxman Nanwani Nanwani, E. Sendagorta, Alberto M. Borobia Pérez
{"title":"Necrólisis epidérmica tóxica causada por Pilexil champú: serenoa serrulata vs hidantoína.","authors":"A. R. Mariblanca, L. D. García, I. García, E. R. García, Kapil Laxman Nanwani Nanwani, E. Sendagorta, Alberto M. Borobia Pérez","doi":"10.24217/2530-4984.17V1S1.00004","DOIUrl":"https://doi.org/10.24217/2530-4984.17V1S1.00004","url":null,"abstract":"","PeriodicalId":257309,"journal":{"name":"IBJ Clinical Pharmacology","volume":"28 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2017-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121964012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The experience of the patient with epidermal necrolysis (TE) in the Getafe Hospital´s Great Burned Unit (GBU) from their own perspective. 表皮坏死松解症(TE)患者在赫塔菲医院大烧伤病房(GBU)的经验。
Pub Date : 2017-11-09 DOI: 10.24217/2530-4984.17v1s1.00001
S. Nuñez, N. Conde, A. González, A. Pérez
{"title":"The experience of the patient with epidermal necrolysis (TE) in the Getafe Hospital´s Great Burned Unit (GBU) from their own perspective.","authors":"S. Nuñez, N. Conde, A. González, A. Pérez","doi":"10.24217/2530-4984.17v1s1.00001","DOIUrl":"https://doi.org/10.24217/2530-4984.17v1s1.00001","url":null,"abstract":"","PeriodicalId":257309,"journal":{"name":"IBJ Clinical Pharmacology","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2017-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121495316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neosensibilización a betalactámicos durante síndrome de DRESS por fenitoína.
Pub Date : 2017-11-09 DOI: 10.24217/2530-4984.17v1s1.00009
Andreina Marques-Mejias, M. Sánchez-Jareño, Ana Fiandor, Rosario Cabañas, Teresa Bellón, Alberto M. Borobia Pérez
{"title":"Neosensibilización a betalactámicos durante síndrome de DRESS por fenitoína.","authors":"Andreina Marques-Mejias, M. Sánchez-Jareño, Ana Fiandor, Rosario Cabañas, Teresa Bellón, Alberto M. Borobia Pérez","doi":"10.24217/2530-4984.17v1s1.00009","DOIUrl":"https://doi.org/10.24217/2530-4984.17v1s1.00009","url":null,"abstract":"","PeriodicalId":257309,"journal":{"name":"IBJ Clinical Pharmacology","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2017-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114807717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
IBJ Clinical Pharmacology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1